[PDF][PDF] Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
KE Rusthoven, BD Kavanagh… - Journal of Clinical …, 2009 - researchgate.net
Journal of Clinical Oncology, 2009•researchgate.net
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Page 1 Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver
Metastases Kyle E. Rusthoven, Brian D. Kavanagh, Higinia Cardenes, Volker W. Stieber, Stuart
H. Burri, Steven J. Feigenberg, Mark A. Chidel, Thomas J. Pugh, Wilbur Franklin, Madeleine
Kane, Laurie E. Gaspar, and Tracey E. Schefter From the University of Colorado— Denver,
Departments of Radiation Oncology, Pathology, and Medical Oncology, Aurora; and St …
Page 1 Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver
Metastases Kyle E. Rusthoven, Brian D. Kavanagh, Higinia Cardenes, Volker W. Stieber, Stuart
H. Burri, Steven J. Feigenberg, Mark A. Chidel, Thomas J. Pugh, Wilbur Franklin, Madeleine
Kane, Laurie E. Gaspar, and Tracey E. Schefter From the University of Colorado— Denver,
Departments of Radiation Oncology, Pathology, and Medical Oncology, Aurora; and St …
Purpose
To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic metastases.
researchgate.net